Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study
- DOI
- 10.1016/j.adro.2024.101532
- Published
- 2024-08
- Container
- Advances in Radiation Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.adro.2024.101532,
title = {Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study},
author = {Benjamin H. Lowentritt and Ashesh B. Jani and Brian T. Helfand and Edward M. Uchio and Michael A. Morris and Jeff M. Michalski and Albert Chau and Phillip Davis and Brian F. Chapin and David M. Schuster},
year = {2024},
journal = {Advances in Radiation Oncology},
doi = {10.1016/j.adro.2024.101532},
url = {https://doi.org/10.1016/j.adro.2024.101532}
}RIS
TY - JOUR TI - Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study AU - Benjamin H. Lowentritt AU - Ashesh B. Jani AU - Brian T. Helfand AU - Edward M. Uchio AU - Michael A. Morris AU - Jeff M. Michalski AU - Albert Chau AU - Phillip Davis AU - Brian F. Chapin AU - David M. Schuster PY - 2024 JO - Advances in Radiation Oncology DO - 10.1016/j.adro.2024.101532 UR - https://doi.org/10.1016/j.adro.2024.101532 ER -
APA
Lowentritt, B. H., Jani, A. B., Helfand, B. T., Uchio, E. M., Morris, M. A., Michalski, J. M., Chau, A., Davis, P., Chapin, B. F., & Schuster, D. M. (2024). Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study. Advances in Radiation Oncology. https://doi.org/10.1016/j.adro.2024.101532
Source records
- crossref · retrieved 2026-09-26T08:44:10.304Z